Deadline: 6-Oct-21
The European Commission (EC) is pleased to launch the European Innovation Council (EIC) Accelerator Open 2021 to support companies (principally start-ups and SMEs) to scale up high impact innovations with the potential to create new markets or disrupt existing ones.
The EIC Accelerator focuses in particular on innovations building on scientific discovery or technological breakthroughs (‘deep tech’) and where significant funding is needed over a long timeframe before returns can be generated (‘patient capital’). Such innovations often struggle to attract financing because the risks and time period involved are too high. Funding and support from the EIC Accelerator is designed to enable such innovators to attract the full investment amounts needed for scale up in a shorter timeframe.
The EIC Accelerator is open to innovations in any field of technology or application. However, innovations that harm the environment or social welfare or that are designed primarily for military applications will not be supported.
The EIC Accelerator supports the later stages of technology development as well as scale-up. The technology component of your innovation must therefore have been tested and validated in a laboratory or other relevant environment (e.g. at least Technology Readiness Level 5/6 or higher). The EIC Accelerator looks to support companies where the EIC support will act as a catalyst to crowd in other investors necessary for the scaleup of the innovation.
Funding Information
The EIC Accelerator provides a unique combination of funding from EUR 0.5 to EUR 17.5 million and Business Acceleration Services.
Eligibility Criteria
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
- the Member States of the European Union, including their outermost regions;
- the Overseas Countries and Territories (OCTs) linked to the Member States;
- eligible non-EU countries:
- countries associated to Horizon Europe;
- low- and middle-income countries.
For more information, visit https://bit.ly/3CYmedx